Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.2B | 1.8B | 1.4B | 1.7B |
| Cost of revenue | 130.4M | 369.8M | 210.7M | 231.5M |
| Gross profit | 1.1B | 1.5B | 1.2B | 1.4B |
| Operating expense | ||||
| Research & development | 394.2M | 498.9M | 449.1M | 448.2M |
| Selling general and admin | 662.9M | -1.5B | 1.9B | -459.5M |
| Other operating expenses | 5.9M | 18.3M | 12.3M | 16.7M |
| Operating income | 46.3M | 78.0M | 43.4M | 279.3M |
| Non operating interest income | ||||
| Income | 8.5M | 8.5M | 5.8M | 13.1M |
| Expense | 591.5K | 678.3K | 450.4K | 9.0M |
| Other income expense | — | — | — | — |
| Pretax income | 50.5M | 17.0M | 46.0M | 225.7M |
| Tax provision | 9.8M | -24.5M | 20.9M | 35.9M |
| Net income | 40.7M | 41.5M | 25.1M | 189.8M |
| Basic EPS | 0.0 | — | — | — |
| Diluted EPS | 0.0 | — | — | — |
| Basic average shares | 1.6B | — | — | — |
| Diluted average shares | 1.6B | — | — | — |
| EBITDA | 51.4M | 91.9M | 38.6M | 297.5M |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -10.9M | -4.3M | -3.7M | -4.1M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |